FMC Corp (FMC) stock

FMCNYSEChemicals & Allied ProductsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 6/30

$5.65+0.01 (+0.18%)

Close on Nov 11, 2026Market cap $878.90MP/E –Yield 32.21%

Earnings

FMC's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report

Feb 3, 2027

Q4 FY2026 · estimated, after the close

Revenue, Q2 FY2026

$867.00M

-17.4% on a year earlier

adjusted earnings per diluted share, Q2 FY2026

$0.26

$0.69 a year earlier

Latest guidance

Lowered

Oct 15, 2026 · 2 items

Quarterly results

Revenue and earnings per share from each of FMC's earnings releases, newest first

Quarter	Reported	Revenue	YoY	EPS	Adj. EPS	Source
Q4 FY2026ended Dec 31, 2026	Feb 3, 2027Expected	–	–	–	–	–
Q3 FY2026ended Sep 30, 2026	Oct 29, 2026after the close	–	–	–	–	Release
Q2 FY2026ended Jun 30, 2026	Jul 29, 2026after the close	$867.00M	-17.4%	-$1.49	$0.26	Release
Q1 FY2026ended Mar 31, 2026	Apr 29, 2026after the close	$759.00M	-4.0%	-$2.25	-$0.23	Release
Q4 FY2025ended Dec 31, 2025	Feb 4, 2026after the close	$1.08B	-11.5%	-$13.74	$1.20	Release
Q3 FY2025ended Sep 30, 2025	Oct 29, 2025after the close	$542.00M	-49.3%	-$4.52	$0.89	Release
Q2 FY2025ended Jun 30, 2025	Jul 30, 2025after the close	$1.05B	+1.0%	$0.53	$0.69	Release
Q1 FY2025ended Mar 31, 2025	Apr 30, 2025after the close	$791.00M	-13.8%	-$0.12	$0.18	Release
Q4 FY2024ended Dec 31, 2024	Feb 4, 2025after the close	$1.22B	+6.1%	-$0.13	$1.79	Release
Q3 FY2024ended Sep 30, 2024	Oct 29, 2024after the close	$1.07B	+9.0%	$0.52	$0.69	Release
Q2 FY2024ended Jun 30, 2024	Jul 31, 2024after the close	$1.04B	+3.0%	$2.35	$0.63	Release
Q1 FY2024ended Mar 31, 2024	May 6, 2024after the close	$918.00M	-31.5%	-$0.02	$0.36	Release
Q4 FY2023ended Dec 31, 2023	Feb 5, 2024after the close	$1.15B	-29.0%	$8.77	$1.07	Release
Q3 FY2023ended Sep 30, 2023	Oct 30, 2023after the close	$982.00M	-28.8%	-$0.03	$0.44	Release
Q2 FY2023ended Jun 30, 2023	Aug 2, 2023after the close	$1.01B	-30.3%	$0.24	$0.50	Release
Q1 FY2023ended Mar 31, 2023	May 1, 2023after the close	$1.34B	-0.7%	$1.55	$1.77	Release
Q4 FY2022ended Dec 31, 2022	Feb 7, 2023after the close	$1.62B	+14.9%	$2.17	$2.37	Release
Q3 FY2022ended Sep 30, 2022	Nov 1, 2022after the close	$1.38B	+16.0%	$0.95	$1.23	Release
Q2 FY2022ended Jun 30, 2022	Aug 2, 2022after the close	$1.45B	–	$1.06	$1.93	Release
Q1 FY2022ended Mar 31, 2022	May 2, 2022after the close	$1.35B	–	$1.64	$1.88	Release
Q4 FY2021ended Dec 31, 2021	Feb 8, 2022after the close	$1.41B	–	$1.52	$2.16	Release
Q3 FY2021ended Sep 30, 2021	Nov 2, 2021after the close	$1.19B	–	$1.22	$1.43	Release
Q2 FY2021ended Jun 30, 2021	Aug 3, 2021after the close	–	–	–	–	Filing
Q1 FY2021ended Mar 31, 2021	May 5, 2021after the close	–	–	–	–	Filing
Q4 FY2020ended Dec 31, 2020	Jan 19, 2021before the open	–	–	–	–	Filing
Q3 FY2020ended Sep 30, 2020	Nov 2, 2020after the close	–	–	–	–	Filing

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

FMC's latest outlook for periods it has not reported yet, compared with what it said before

Metric	Period	Guidance	Before	Change	Given
revenueGAAP	Q3 FY2026	$65.00M – $125.00M	–	New	Oct 15, 2026
revenue excluding Indianon-GAAP	Q3 FY2026	$840.00M – $900.00M	–	New	Jul 29, 2026
Adjusted EBITDAnon-GAAP	Q3 FY2026	-$565.00M – -$510.00M	$120.00M – $140.00M	Lowered	Oct 15, 2026
adjusted earnings per diluted sharenon-GAAP	Q3 FY2026	$0.05 – $0.13	–	New	Jul 29, 2026
revenue excluding Indianon-GAAP	Q4 FY2026	$1.06B – $1.20B	–	New	Jul 29, 2026
Adjusted EBITDAnon-GAAP	Q4 FY2026	$275.00M – $315.00M	–	New	Jul 29, 2026
adjusted earnings per diluted sharenon-GAAP	Q4 FY2026	$1.09 – $1.33	–	New	Jul 29, 2026
Revenue excluding Indianon-GAAP	FY2026	$3.50B – $3.70B	$3.60B – $3.80B	Lowered	Jul 29, 2026
Revenue excluding India growth at midpoint vs. 2025non-GAAP	FY2026	-5%	–	New	Apr 29, 2026
Adjusted EBITDAnon-GAAP	FY2026	$620.00M – $680.00M	$670.00M – $730.00M	Lowered	Jul 29, 2026
Adjusted EBITDA growth at midpointnon-GAAP	FY2026	-17%	–	New	Apr 29, 2026
Adjusted earnings per diluted share growth at midpointnon-GAAP	FY2026	-41%	–	New	Apr 29, 2026
Adjusted EPSnon-GAAP	FY2026	$1.19 – $1.49	$1.63 – $1.89	Lowered	Jul 29, 2026
Free cash flownon-GAAP	FY2026	$75.00M – $225.00M	-$65.00M – $65.00M	Raised	Jul 29, 2026
Sales of new active ingredients	FY2026	$300.00M – $400.00M	–	New	Apr 29, 2026

Guidance vs results

The last range FMC gave before each report, against the figure it then reported. Full years add up the four quarters.

Period	Metric	Guidance	Actual	Result
Q2 FY2026	Adjusted EPS	$0.16 – $0.26	$0.26	Within range
Q2 FY2026	Revenue	$850.00M – $900.00M	$867.00M	Within range
Q2 FY2026	Revenue growth	-17%	-17.43%	Below range
Q1 FY2026	Adjusted EPS	-$0.44 – -$0.32	-$0.23	Above range
Q1 FY2026	Revenue	$725.00M – $775.00M	$759.00M	Within range
FY2025	Adjusted earnings per diluted share outlook	$2.92 – $3.14	$2.96Σ4Q	Within range
FY2025	Revenue	$3.92B – $4.02B	$3.46BΣ4Q	Below range
Q4 FY2025	adjusted earnings per diluted share	$1.62 – $1.84	$1.20	Below range
Q4 FY2025	Revenue growth	+5%	-11.48%	Below range
Q3 FY2025	adjusted earnings per diluted share	$0.78 – $0.98	$0.89	Within range
Q3 FY2025	Revenue growth	-1%	-49.35%	Below range
Q2 FY2025	adjusted earnings per diluted share	$0.52 – $0.68	$0.69	Above range
Q2 FY2025	Revenue	$940.00M – $1.10M	$1.05B	Above range
Q1 FY2025	Adjusted EPS	$0.05 – $0.15	$0.18	Above range
Q1 FY2025	Revenue	$750.00M – $800.00M	$791.00M	Within range
Q4 FY2024	adjusted earnings per diluted share	$1.47 – $1.83	$1.79	Within range
Q4 FY2024	Revenue	$1.30B – $1.41B	$1.22B	Below range
Q3 FY2024	adjusted earnings per diluted share	$0.39 – $0.67	$0.69	Above range
Q3 FY2024	Revenue	$1.00B – $1.09B	$1.07B	Within range
Q2 FY2024	adjusted earnings per diluted share	$0.43 – $0.72	$0.63	Within range
Q2 FY2024	Revenue	$1.00B – $1.15B	$1.04B	Within range
Q1 FY2024	Adjusted EPS	$0.21 – $0.43	$0.36	Within range
Q4 FY2023	adjusted earnings per diluted share	$0.89 – $1.38	$1.07	Within range
Q4 FY2023	Revenue	$1.14B – $1.38B	$1.15B	Within range
Q3 FY2023	adjusted earnings per diluted share	$0.90 – $1.32	$0.44	Below range
Q3 FY2023	Revenue	$1.19B – $1.27B	$982.00M	Below range
Q2 FY2023	adjusted earnings per diluted share	$1.66 – $1.86	$0.50	Below range
Q2 FY2023	Revenue	$1.42B – $1.48B	$1.01B	Below range
Q1 FY2023	Adjusted earnings per diluted share	$1.63 – $1.83	$1.77	Within range
Q1 FY2023	Revenue	$1.41B – $1.45B	$1.34B	Below range
Q4 FY2022	adjusted earnings per diluted share	$2.05 – $2.55	$2.37	Within range
Q4 FY2022	Revenue	$1.42B – $1.62B	$1.62B	Within range
Q3 FY2022	adjusted earnings per diluted share	$1.00 – $1.20	$1.23	Above range
Q3 FY2022	Revenue	$1.31B – $1.39B	$1.38B	Within range
Q2 FY2022	adjusted earnings per diluted share	$1.70 – $2.00	$1.93	Within range
Q2 FY2022	Revenue	$1.31B – $1.39B	$1.45B	Above range
Q1 FY2022	adjusted earnings per diluted share	$1.50 – $1.90	$1.88	Within range
Q1 FY2022	Revenue	$1.22B – $1.34B	$1.35B	Above range
Q4 FY2021	adjusted earnings per diluted share	$1.80 – $2.20	$2.16	Within range
Q4 FY2021	Revenue	$1.27B – $1.47B	$1.41B	Within range

Guidance history

Every forecast FMC put in an earnings release, newest first

Given	Metric	Period	Guidance	Change
Oct 15, 2026	Adjusted EBITDA	Q3 FY2026	-$565.00M – -$510.00M	Lowered
Oct 15, 2026	revenue	Q3 FY2026	$65.00M – $125.00M	New
Jul 29, 2026	Adjusted EBITDA	FY2026	$620.00M – $680.00M	Lowered
Jul 29, 2026	Adjusted EBITDA	Q3 FY2026	$120.00M – $140.00M	New
Jul 29, 2026	Adjusted EBITDA	Q4 FY2026	$275.00M – $315.00M	New
Jul 29, 2026	Adjusted EPS	FY2026	$1.19 – $1.49	Lowered
Jul 29, 2026	adjusted earnings per diluted share	Q3 FY2026	$0.05 – $0.13	New
Jul 29, 2026	adjusted earnings per diluted share	Q4 FY2026	$1.09 – $1.33	New
Jul 29, 2026	Free cash flow	FY2026	$75.00M – $225.00M	Raised
Jul 29, 2026	Revenue excluding India	FY2026	$3.50B – $3.70B	Lowered
Jul 29, 2026	revenue excluding India	Q3 FY2026	$840.00M – $900.00M	New
Jul 29, 2026	revenue excluding India	Q4 FY2026	$1.06B – $1.20B	New
Apr 29, 2026	Adjusted EBITDA growth at midpoint	FY2026	-17%	New
Apr 29, 2026	Adjusted EBITDA	FY2026	$670.00M – $730.00M	Reaffirmed
Apr 29, 2026	Adjusted EBITDA	Q2 FY2026	+130% – +150%	New
Apr 29, 2026	Adjusted EBITDA decline	Q2 FY2026	-32%	Lowered
Apr 29, 2026	Adjusted earnings per diluted share growth at midpoint	FY2026	-41%	New
Apr 29, 2026	Adjusted earnings per diluted share	FY2026	$1.63 – $1.89	Reaffirmed
Apr 29, 2026	Adjusted EPS decrease at midpoint	Q2 FY2026	-70%	New
Apr 29, 2026	Adjusted EPS	Q2 FY2026	$0.16 – $0.26	New
Apr 29, 2026	Free cash flow	FY2026	-$65.00M – $65.00M	Reaffirmed
Apr 29, 2026	Sales of new active ingredients	FY2026	$300.00M – $400.00M	New
Apr 29, 2026	Revenue excluding India growth at midpoint vs. 2025	FY2026	-5%	New
Apr 29, 2026	Revenue excluding India	FY2026	$3.60B – $3.80B	Reaffirmed
Apr 29, 2026	Second quarter revenue decline at midpoint	Q2 FY2026	-17%	New
Apr 29, 2026	Second quarter revenue	Q2 FY2026	$850.00M – $900.00M	New
Feb 4, 2026	Adjusted EBITDA	FY2026	$670.00M – $730.00M	New
Feb 4, 2026	Adjusted EBITDA	Q1 FY2026	$45.00M – $55.00M	New
Feb 4, 2026	Adjusted EPS	FY2026	$1.63 – $1.89	New
Feb 4, 2026	Adjusted EPS	Q1 FY2026	-$0.44 – -$0.32	New
Feb 4, 2026	Free cash flow	FY2026	-$65.00M – $65.00M	New
Feb 4, 2026	revenue guidance	FY2026	$3.60B – $3.80B	New
Feb 4, 2026	revenue guidance	Q1 FY2026	$725.00M – $775.00M	New
Oct 29, 2025	Adjusted EBITDA outlook	FY2025	$830.00M – $870.00M	New
Oct 29, 2025	Adjusted EBITDA	Q4 FY2025	$265.00M – $305.00M	Lowered
Oct 29, 2025	Adjusted earnings per diluted share outlook	FY2025	$2.92 – $3.14	New
Oct 29, 2025	Free cash flow forecast	FY2025	-$200.00M – $0	New
Oct 29, 2025	Revenue outlook	FY2025	$3.92B – $4.02B	New
Oct 29, 2025	Fourth quarter revenue excluding India	Q4 FY2025	$1.12B – $1.22B	Lowered
Jul 30, 2025	increase at the midpoint versus the prior year	Q3 FY2025	+14%	New
Jul 30, 2025	Adjusted EBITDA	Q3 FY2025	$210.00M – $250.00M	New
Jul 30, 2025	increase at the midpoint versus the prior year	Q4 FY2025	+4%	New
Jul 30, 2025	Adjusted EBITDA	Q4 FY2025	$334.00M – $374.00M	New
Jul 30, 2025	Growth at midpoint vs. 2024	FY2025	+1%	New
Jul 30, 2025	adjusted EBITDA outlook	FY2025	$870.00M – $950.00M	Reaffirmed
Jul 30, 2025	Adjusted EBITDA	FY2025	$544.00M – $624.00M	Lowered
Jul 30, 2025	increase at the midpoint versus third quarter 2024	Q3 FY2025	+28%	New
Jul 30, 2025	adjusted earnings per diluted share	Q3 FY2025	$0.78 – $0.98	New
Jul 30, 2025	decrease at the midpoint versus fourth quarter 2024	Q4 FY2025	-3%	New
Jul 30, 2025	adjusted earnings per diluted share	Q4 FY2025	$1.62 – $1.84	New
Jul 30, 2025	Adjusted earnings per diluted share outlook	FY2025	$3.26 – $3.70	Reaffirmed
Jul 30, 2025	Adjusted EPS	FY2025	$2.40 – $2.82	Lowered
Jul 30, 2025	Free cash flow forecast midpoint change	FY2025	-51%	New
Jul 30, 2025	Free cash flow forecast	FY2025	$200.00M – $400.00M	Reaffirmed
Jul 30, 2025	midpoint growth vs. reported third quarter 2024	Q3 FY2025	-1%	New
Jul 30, 2025	Third quarter revenue excluding India	Q3 FY2025	$1.00B – $1.10B	New
Jul 30, 2025	increase at the midpoint versus reported fourth quarter 2024	Q4 FY2025	+5%	New
Jul 30, 2025	Fourth quarter revenue excluding India	Q4 FY2025	$1.24B – $1.34B	New
Jul 30, 2025	Growth at midpoint vs. 2024	FY2025	-2%	New
Jul 30, 2025	Revenue outlook	FY2025	$4.08B – $4.28B	Lowered
Jul 30, 2025	Revenue	FY2025	$2.24B – $2.44B	Lowered
Apr 30, 2025	Adjusted EBITDA	Q2 FY2025	$175.00M – $205.00M	New
Apr 30, 2025	adjusted EBITDA	FY2025	$870.00M – $950.00M	Reaffirmed
Apr 30, 2025	adjusted earnings per diluted share	Q2 FY2025	$0.52 – $0.68	New
Apr 30, 2025	Adjusted earnings per diluted share	FY2025	$3.26 – $3.70	Reaffirmed
Apr 30, 2025	Free cash flow	FY2025	$200.00M – $400.00M	Reaffirmed
Apr 30, 2025	revenue	Q2 FY2025	$940.00M – $1.10M	New
Apr 30, 2025	revenue	FY2025	$4.15B – $4.35B	New
Feb 4, 2025	Adjusted EBITDA	Q1 FY2025	$105.00M – $125.00M	New
Feb 4, 2025	Adjusted EBITDA	FY2025	$870.00M – $950.00M	New
Feb 4, 2025	Adjusted EPS	Q1 FY2025	$0.05 – $0.15	New
Feb 4, 2025	Adjusted earnings per diluted share	FY2025	$3.26 – $3.70	New
Feb 4, 2025	Free cash flow	FY2025	$200.00M – $400.00M	New
Feb 4, 2025	Revenue	Q1 FY2025	$750.00M – $800.00M	New
Feb 4, 2025	Revenue	FY2025	$4.15B – $4.35B	New
Oct 29, 2024	Adjusted EBITDA	Q4 FY2024	$321.00M – $351.00M	Lowered
Oct 29, 2024	Adjusted EBITDA outlook range	FY2024	$885.00M – $915.00M	Narrowed
Oct 29, 2024	adjusted earnings per diluted share	Q4 FY2024	$1.47 – $1.83	Lowered
Oct 29, 2024	Adjusted earnings per diluted share outlook range	FY2024	$3.16 – $3.52	Narrowed
Oct 29, 2024	Free cash flow outlook range	FY2024	$400.00M – $500.00M	Reaffirmed
Oct 29, 2024	tax rate range	FY2024	13% – 15%	New
Oct 29, 2024	target restructuring savings range	FY2024	$125.00M – $150.00M	New
Oct 29, 2024	Fourth quarter revenue	Q4 FY2024	$1.30B – $1.41B	Lowered
Oct 29, 2024	Revenue outlook	FY2024	$4.33B – $4.44B	Narrowed
Jul 31, 2024	Adjusted EBITDA	Q3 FY2024	$165.00M – $195.00M	New
Jul 31, 2024	Adjusted EBITDA	Q4 FY2024	$353.00M – $383.00M	New
Jul 31, 2024	Adjusted EBITDA	FY2024	$518.00M – $578.00M	New
Jul 31, 2024	adjusted EBITDA	FY2024	$880.00M – $940.00M	Raised
Jul 31, 2024	adjusted earnings per diluted share	Q3 FY2024	$0.39 – $0.67	New
Jul 31, 2024	adjusted earnings per diluted share	Q4 FY2024	$1.64 – $1.96	New
Jul 31, 2024	adjusted earnings	FY2024	$3.02 – $3.64	Lowered
Jul 31, 2024	free cash flow	FY2024	$400.00M – $500.00M	Lowered
Jul 31, 2024	revenue	Q3 FY2024	$1.00B – $1.09B	New
Jul 31, 2024	revenue	Q4 FY2024	$1.34B – $1.45B	New
Jul 31, 2024	Sales	FY2024	$2.34B – $2.54B	Lowered
Jul 31, 2024	revenue	FY2024	$4.30B – $4.50B	Raised
May 6, 2024	Adjusted EBITDA	Q2 FY2024	$170.00M – $210.00M	New
May 6, 2024	adjusted earnings per diluted share	Q2 FY2024	$0.43 – $0.72	New
May 6, 2024	adjusted earnings	FY2024	$3.23 – $4.41	Reaffirmed
May 6, 2024	free cash flow	FY2024	$400.00M – $600.00M	Reaffirmed
May 6, 2024	revenue	Q2 FY2024	$1.00B – $1.15B	New
May 6, 2024	revenue	FY2024	$4.50B – $4.70B	Reaffirmed
Feb 5, 2024	Adjusted EBITDA	Q1 FY2024	$135.00M – $165.00M	New
Feb 5, 2024	Adjusted EPS	Q1 FY2024	$0.21 – $0.43	New
Feb 5, 2024	Adjusted earnings per diluted share	FY2024	$3.23 – $4.41	New
Feb 5, 2024	Free cash flow	FY2024	$400.00M – $600.00M	New
Feb 5, 2024	Revenue	FY2024	$4.50B – $4.70B	New
Oct 30, 2023	Adjusted EBITDA	Q4 FY2023	$246.00M – $306.00M	Lowered
Oct 30, 2023	adjusted EBITDA	FY2023	$970.00M – $1.03B	Raised
Oct 30, 2023	adjusted earnings per diluted share	Q4 FY2023	$0.89 – $1.38	Lowered
Oct 30, 2023	adjusted earnings	FY2023	$3.57 – $4.13	Lowered
Oct 30, 2023	free cash flow	FY2023	-$860.00M – -$640.00M	Lowered
Oct 30, 2023	revenue	Q4 FY2023	$1.14B – $1.38B	New
Oct 30, 2023	revenue	FY2023	$4.48B – $4.72B	Lowered
Aug 2, 2023	Adjusted EBITDA	Q3 FY2023	$240.00M – $290.00M	New
Aug 2, 2023	Adjusted EBITDA	Q4 FY2023	$511.00M – $561.00M	New
Aug 2, 2023	adjusted EBITDA	FY2023	$1.30B – $1.40B	Lowered
Aug 2, 2023	Adjusted EBITDA	FY2023	$751.00M – $851.00M	Lowered
Aug 2, 2023	adjusted earnings per diluted share	Q3 FY2023	$0.90 – $1.32	New
Aug 2, 2023	adjusted earnings per diluted share	Q4 FY2023	$2.71 – $3.17	New
Aug 2, 2023	adjusted earnings	FY2023	$5.86 – $6.80	Lowered
Aug 2, 2023	Adjusted EPS	FY2023	$3.61 – $4.49	Lowered
Aug 2, 2023	free cash flow	FY2023	-$175.00M – $175.00M	Lowered
Aug 2, 2023	revenue	Q3 FY2023	$1.19B – $1.27B	New
Aug 2, 2023	revenue	Q4 FY2023	$1.66B – $1.78B	New
Aug 2, 2023	revenue	FY2023	$5.20B – $5.40B	New
Aug 2, 2023	Sales	FY2023	$2.84B – $3.04B	Lowered
May 1, 2023	Adjusted EBITDA	Q2 FY2023	$350.00M – $370.00M	New
May 1, 2023	adjusted EBITDA	FY2023	$1.50B – $1.56B	Raised
May 1, 2023	adjusted earnings per diluted share	Q2 FY2023	$1.66 – $1.86	New
May 1, 2023	adjusted earnings	FY2023	$7.34 – $7.94	Narrowed
May 1, 2023	free cash flow	FY2023	$530.00M – $720.00M	Reaffirmed
May 1, 2023	revenue	Q2 FY2023	$1.42B – $1.48B	New
May 1, 2023	revenue	FY2023	$6.08B – $6.22B	Reaffirmed
Feb 7, 2023	Adjusted EBITDA	Q1 FY2023	$345.00M – $365.00M	New
Feb 7, 2023	adjusted EBITDA	FY2023	$1.48B – $1.56B	New
Feb 7, 2023	Adjusted earnings per diluted share	Q1 FY2023	$1.63 – $1.83	New
Feb 7, 2023	adjusted earnings per share (EPS)	FY2023	$7.20 – $8.00	New
Feb 7, 2023	free cash flow	FY2023	$530.00M – $720.00M	New
Feb 7, 2023	Interest expense	FY2023	$200.00M – $210.00M	New
Feb 7, 2023	revenue	Q1 FY2023	$1.41B – $1.45B	New
Feb 7, 2023	revenue	FY2023	$6.08B – $6.22B	New
Nov 1, 2022	Adjusted EBITDA	Q4 FY2022	$395.00M – $455.00M	Lowered
Nov 1, 2022	adjusted EBITDA	FY2022	$1.37B – $1.43B	Raised
Nov 1, 2022	adjusted earnings per diluted share	Q4 FY2022	$2.05 – $2.55	Lowered
Nov 1, 2022	adjusted earnings per share	FY2022	$7.10 – $7.60	Narrowed
Nov 1, 2022	free cash flow	FY2022	$440.00M – $560.00M	Lowered
Nov 1, 2022	Interest expense	FY2022	$148.00M – $154.00M	Narrowed
Nov 1, 2022	revenue	Q4 FY2022	$1.42B – $1.62B	Raised
Nov 1, 2022	revenue	FY2022	$5.60B – $5.80B	Raised
Aug 2, 2022	Adjusted EBITDA	Q3 FY2022	$235.00M – $255.00M	New
Aug 2, 2022	Adjusted EBITDA	Q4 FY2022	$411.00M – $471.00M	New
Aug 2, 2022	adjusted EBITDA	FY2022	$1.36B – $1.44B	Narrowed
Aug 2, 2022	Adjusted EBITDA	FY2022	$646.00M – $726.00M	Lowered
Aug 2, 2022	adjusted earnings per diluted share	Q3 FY2022	$1.00 – $1.20	New
Aug 2, 2022	adjusted earnings per diluted share	Q4 FY2022	$2.18 – $2.70	New
Aug 2, 2022	adjusted earnings per share	FY2022	$7.00 – $7.70	Narrowed
Aug 2, 2022	free cash flow	FY2022	$565.00M – $685.00M	Narrowed
Aug 2, 2022	Interest expense	FY2022	$135.00M – $155.00M	Lowered
Aug 2, 2022	revenue	Q3 FY2022	$1.31B – $1.39B	New
Aug 2, 2022	revenue	Q4 FY2022	$1.39B – $1.51B	New
Aug 2, 2022	revenue	FY2022	$5.50B – $5.70B	Raised
Aug 2, 2022	Sales	FY2022	$2.70B – $2.90B	Lowered
May 2, 2022	Adjusted EBITDA	Q2 FY2022	$330.00M – $370.00M	New
May 2, 2022	adjusted EBITDA	FY2022	$1.32B – $1.48B	Reaffirmed
May 2, 2022	adjusted earnings per diluted share	Q2 FY2022	$1.70 – $2.00	New
May 2, 2022	adjusted earnings per share	FY2022	$6.70 – $8.00	Lowered
May 2, 2022	free cash flow	FY2022	$515.00M – $735.00M	Reaffirmed
May 2, 2022	revenue	Q2 FY2022	$1.31B – $1.39B	New
May 2, 2022	revenue	FY2022	$5.25B – $5.55B	New
Feb 8, 2022	Adjusted EBITDA	Q1 FY2022	$300.00M – $350.00M	New
Feb 8, 2022	Adjusted EBITDA	FY2022	$1.32B – $1.48B	New
Feb 8, 2022	adjusted earnings per diluted share	Q1 FY2022	$1.50 – $1.90	New
Feb 8, 2022	Adjusted earnings per diluted share	FY2022	$6.80 – $8.10	New
Feb 8, 2022	Free cash flow	FY2022	$515.00M – $735.00M	New
Feb 8, 2022	repurchase ... FMC shares	FY2022	$500.00M – $600.00M	New
Feb 8, 2022	revenue	Q1 FY2022	$1.22B – $1.34B	New
Feb 8, 2022	Revenue	FY2022	$5.25B – $5.55B	New
Nov 2, 2021	Adjusted EBITDA	Q4 FY2021	$343.00M – $403.00M	New
Nov 2, 2021	adjusted EBITDA	FY2021	$1.29B – $1.35B	New
Nov 2, 2021	adjusted earnings per diluted share	Q4 FY2021	$1.80 – $2.20	New
Nov 2, 2021	adjusted earnings	FY2021	$6.59 – $6.99	New
Nov 2, 2021	free cash flow	FY2021	$480.00M – $570.00M	New
Nov 2, 2021	revenue	Q4 FY2021	$1.27B – $1.47B	New
Nov 2, 2021	revenue	FY2021	$4.90B – $5.10B	New

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.